Track RXRX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
RXRX - Recursion Pharmaceuticals Inc (RXRX) has a earnings per share of -$0.22, up 56.0% over the past year.
Latest EPS (Actual)
-$0.22
Beat Rate
37.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.26 | -$0.22 | Beat | +15.38% |
| Feb 2026 | -$0.30 | -$0.21 | Beat | +30.00% |
| Nov 2025 | -$0.38 | -$0.36 | Beat | +5.26% |
| Aug 2025 | -$0.35 | -$0.41 | Miss | -17.14% |
| May 2025 | -$0.52 | -$0.50 | Meet | +3.85% |
| Feb 2025 | -$0.42 | -$0.53 | Miss | -27.16% |
| Nov 2024 | -$0.33 | -$0.34 | Meet | -3.03% |
| Aug 2024 | -$0.38 | -$0.40 | Miss | -5.26% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.